WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009063364) MODULATORS OF UROTENSIN RECEPTOR AND METHODS OF USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/063364    International Application No.:    PCT/IB2008/054633
Publication Date: 22.05.2009 International Filing Date: 06.11.2008
IPC:
C07D 487/08 (2006.01), A61K 31/4995 (2006.01), A61P 9/00 (2006.01), A61P 25/00 (2006.01), A61P 1/12 (2006.01), A61P 3/10 (2006.01)
Applicants: ENCYSIVE PHARMACEUTICALS INC. [US/US]; 235 East 42nd Street, New York, New York 10017 (US) (For All Designated States Except US).
GAO, Daxin [CN/US]; (US) (For US Only).
WU, Chengde [US/CN]; (US) (For US Only)
Inventors: GAO, Daxin; (US).
WU, Chengde; (US)
Agent: FULLER JR., Grover F.; Pfizer Inc. 235 East 42nd Street, New York, New York 10017 (US)
Priority Data:
61/002,974 13.11.2007 US
Title (EN) MODULATORS OF UROTENSIN RECEPTOR AND METHODS OF USE THEREOF
(FR) MODULATEURS DU RÉCEPTEUR DE L'UROTENSINE ET LEURS MÉTHODES D'UTILISATION
Abstract: front page image
(EN)Provided are compounds that are modulators of urotensin-II receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, provided are methods for treating or ameliorating diseases associated with modulation of urotensin-II receptor activity wherein the disease is a cardiovascular disorder, atherosclerosis, renal failure, nephrotoxicity and diarrhea caused by antineoplastic agents, post-myocardial infarction, pulmonary hypertension, diabetes or a CNS related disease.
(FR)L'invention porte sur des composés modulateurs de l'activité du récepteur de l'urotensine II, sur des compositions contenant lesdits composés, et sur les méthodes d'utilisation des composés et des compositions. Certaines exécutions portent sur des méthodes de traitement et d'amélioration de maladies associées à la modulation de l'activité du récepteur de l'urotensine II.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)